Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve isoquinolinone synthesis challenges with high-yield, one-pot method. Reduce costs, improve safety, and ensure consistent supply for your drug development projects.
Solve amide synthesis challenges with metal-free NHC catalysis: 93-96% yields, 15-min reactions, no metal residues. Reduce costs and supply chain risks for pharma intermediates.
Discover how recent photocatalytic synthesis of beta-chloroesters eliminates pre-functionalization needs, reduces supply chain risks, and achieves >60% yields for pharmaceutical intermediates.
Solve supply chain risks with mild, high-yield synthesis of benzodihydrofuran intermediates. 80%+ yields, functional group tolerance, and scalable production for pharma R&D and procurement.
Discover how metal-free catalysis for 2-methylpyridine synthesis reduces production costs by 30% while eliminating hazardous waste. Ideal for pharma R&D and procurement teams.
Solve high-cost catalysts and low yields in alpha-aryl carbonyl synthesis. New phosphorus ylide-based catalysts enable 90%+ yields with cheap chloroarenes, reducing supply chain risks for pharma R&D and production.
Discover how composite catalysis of 2-cyano-2-valproic acid ester reduces costs and improves purity for valproate production, ensuring supply chain stability.
Solve high-cost synthesis challenges of thienoindole derivatives with nickel-catalyzed one-pot process. 96% yield, >99% purity, and simplified purification for R&D and procurement teams.
Overcome low yields and poor regioselectivity in benzoxepin synthesis. Our CDMO expertise delivers 75%+ yields with broad functional group tolerance for stable API supply chains.
Discover iodine-catalyzed imidazo[1,2-a]pyridine synthesis with 86% yield, no metal residues, and mild conditions. Solve GMP compliance and cost challenges for drug development.
Solve high-cost synthesis challenges for 2-trifluoromethyl quinazolinones. Our CDMO expertise delivers scalable, high-yield routes for drug development.
Discover how novel C-H activation methods for polysubstituted isoquinolines reduce catalyst costs and improve yield in pharmaceutical synthesis. Contact us for custom manufacturing.
Avoid hazardous reagents and boost yield to 85% with eco-friendly Zopiclone synthesis. Reduce waste and simplify production for sleep disorder treatments.
Discover a novel one-pot synthesis for triarylmethane compounds with low catalyst loading, high yields, and mild conditions. Ideal for scalable production of pharmaceutical intermediates with reduced supply chain risks.
Solve acridine synthesis challenges with high-yield, scalable palladium-catalyzed routes. Reduce costs and supply risks for pharmaceutical intermediates. Contact us for custom synthesis.
Solve CO gas handling risks in biheterocyclic synthesis. Our CDMO scales this patent-protected method to 100MT/yr with >99% purity. Contact for COA/MSDS.
Eliminate CO gas risks and high costs in biheterocyclic synthesis. Our CDMO expertise scales this CO-free palladium method for high-purity pharmaceutical intermediates with >99% purity.
Solve indole synthesis challenges with this one-step nickel-catalyzed method. Achieve >90% yields, broad functional group tolerance, and simplified purification for your API production.
Discover air-tolerant, heavy-metal-free synthesis of trifluoromethyl-1,2,4-triazine compounds with 65-87% yields. Reduce supply chain risks and production costs for pharmaceutical intermediates.
Discover how palladium-catalyzed defluoroalkynylation enables 69% yield, 98% purity, and cost-efficient synthesis of 2-fluoroalkyl-3-alkynyl naphthofuran for pharmaceutical R&D and supply chain stability.